Allogeneic bone marrow transplantation in adrenoleukodystrophy: Clinical, pathologic, and biochemical studies

A. M. Yeager, H. W. Moser, P. J. Tutschka, R. Saral, A. A. Kumar, G. W. Santos

Research output: Contribution to journalArticle

6 Scopus citations

Abstract

The biochemical defect in ALD is due to impaired oxidation of VLCFA within the peroxisomes, subcellular organelles in which a wide range of activities occur, including β-oxidation of long-chain fatty acids and synthesis of bile acids and glycerolipids. The observation that normal leukocytes can oxidize VLCFA, and the encouraging clinical reports of allogeneic bone marrow transplantation (BMT) for various lysosomal storage diseases, along with the lack of other therapeutic options, led us to perform BMT in a 12 1/2 -year-old boy with rapidly progressive ALD. In this report we describe the clinical course and the biochemical and neuropathologic findings in our patient after allogeneic BMT from an unaffected normal MHC-matched brother.

Original languageEnglish (US)
Pages (from-to)79-100
Number of pages22
JournalBirth Defects: Original Article Series
Volume22
Issue number1
StatePublished - Dec 1 1986

ASJC Scopus subject areas

  • Developmental Biology
  • Genetics(clinical)

Fingerprint Dive into the research topics of 'Allogeneic bone marrow transplantation in adrenoleukodystrophy: Clinical, pathologic, and biochemical studies'. Together they form a unique fingerprint.

  • Cite this